US Wound Care Market

The US wound care market is projected to reach USD 9.44 billion by 2031 from USD 7.01 billion in 2026, at a CAGR of 6.1% during the forecast period. Wound care products play a crucial role in treating various types of wounds by facilitating natural healing and serving as a protective barrier against infection. These products include innovative, surgical, and traditional wound care products, leading to efficient outcomes. Wound care products are accessible and are used in hospitals and clinics, long-term care settings, and in-home care settings.

• In March 2025, Convatec Group PLC (UK) and the Wound, Ostomy and Continence Nurses Society (US) collaborated to launch two free educational programs to improve ostomy care knowledge for healthcare professionals.
• In July 2024, Owens & Minor (US) acquired Rotech Healthcare (US) for USD 1.36 billion. This acquisition strengthens Owens & Minor's presence in the home-based care segment, expanding its services and capabilities.

The key players in this market Solventum (US), Johnson & Johnson Services, Inc. (US),  Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity Aktlebolag (Sweden), Avery Dennison Corporation (US), Mativ Holdings, Inc. (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Medtronic (Ireland), and Baxter (US), among others. These players have employed a range of organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to enhance their international footprint and increase their share of the US wound care market.

To know about the assumptions considered for the study download the pdf brochure

Solventum (US)

Immediately after its April 2024 spinoff from 3M, Solventum was on a path to remain an independent company. While it had benefited from 3M's resources and brand awareness, it set out to establish its own path. The company designs, manufactures, and markets a broad array of products that help address the needs of patients and healthcare professionals alike. Its activities are organized into four strategic business units: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. Solventum is focusing on growth across its businesses through innovation and strategic expansion. The company enhances its competitive position by combining materials science with digital technologies, driving better clinical and economic outcomes for healthcare systems.

Johnson & Johnson Services, Inc. (US)

Johnson & Johnson, one of the leading global healthcare conglomerates, remains at the forefront of the wound care industry through its surgical technology business division, Ethicon. The company offers a broad range of sophisticated wound closure products, including sutures, staplers, and sealants, that cater to surgical and acute care settings. With its rich experience and expertise in the healthcare industry, the company effectively meets the diverse needs of surgical wound care. With the extensive global manufacturing and distribution network provided by Johnson & Johnson, Ethicon enhances the company’s capacity to offer high-quality, scalable, and reliable wound care products worldwide.

Market Ranking

In the US wound care market, leading companies such as Solventum (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Cardinal Health (US), and Mölnlycke AB (Sweden) play pivotal roles through their broad wound care portfolios and continuous technological innovation.

Solventum is recognized for its wound management and medical-surgical offerings, with a significant emphasis on solutions that facilitate faster healing, protect against infection, and ensure predictable healing outcomes in both in-hospital and out-of-hospital environments. The company also specializes in negative-pressure wound therapy and advanced dressings for complex wounds. Johnson & Johnson, with its Med Tech business (including Ethicon brands), boasts significant capabilities in surgical wound-closure solutions, supporting post-surgical patients with a diverse range of offerings in sutures and stapling. These solutions aid surgeons during surgical interventions and post-surgical recoveries. Cardinal Health boasts a significant wound care presence with its wound dressing and wound management solutions, providing protection and promoting healing with dressings and sustained care solutions for wounds by providing a protective barrier for wounds and their exudate while promoting a moist environment for sustained healing solutions for both acute and home care patients. Smith+Nephew boasts significant capabilities in advanced wound management solutions with offerings for chronic and acute wounds (focusing on diabetic, pressure, venous, burn, and post-surgical wounds) using advanced dressings and negative-pressure wound therapies, with significant capabilities for improved healing and avoiding preventable complications for patients with chronic and acute wounds. Mölnlycke boasts significant capabilities in wound dressings, with notable innovations in soft silicone dressings that offer significantly less painful and traumatic wound dressing changes, while providing highly efficient exudate management solutions for patients with chronic and post-surgical wounds.

Related Reports:

US Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care]-Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com